Answers are grounded in this paper and cite their sources.
Sexual dysfunction is a prevalent health condition that significantly impacts quality of life (QOL). A 2024 meta-analysis estimated the prevalence at 31% in men and 41% in women.1 Despite this high prevalence, utilization of sexual health care services remains remarkably low. The Global Study of Sexual Attitudes and Behaviors, which surveyed 27 500 individuals across 29 countries, demonstrated that consultation rates for sexual dysfunction were lower in East Asia than in other regions despite high prevalence, suggesting cultural influences.2 In Japan, where discussing sexual issues is considered taboo particularly for women, barriers to seeking care may exist. Lafortune et al. reported that among individuals seeking professional services for sexual dysfunction, 39.6% were unable to access care, with barriers including cost, lack of information, shame, and stigma.3 While clinical guidelines for male sexual dysfunction have long been established, international guidelines for female sexual dysfunction have also emerged, including those from the International Society for the Study of Women's Sexual Health (ISSWSH) and the European Society for Sexual Medicine (ESSM); however, in Japan, equivalent treatment frameworks remain underdeveloped and specialized clinics are limited. Yet no study has statistically examined barriers to care-seeking by sex and age in Japan. This multicenter cross-sectional study was conducted at 5 medical facilities in [blinded], Japan, from February to August 2025: [Institution A] (university hospital), [Institution B] (general hospital), [Institution C] (general hospital), [Institution D] (women’s urogynecology clinic), and [Institution E] (obstetrics and reproductive medicine clinic). Participants were outpatients aged 18-79 years. A study-specific self-administered questionnaire was developed by the authors to assess awareness of sexual dysfunction (know/heard of but don’t know details/don’t know), intention to visit a sexual dysfunction clinic (would not want to/would want to but have reservations/would actively want to), barriers to visiting, priorities when visiting, and preferred physician sex. We performed logistic regression analyses adjusting for sex, age, and institution. For age-stratified analysis, participants were categorized into 3 groups: <40 years, 40-64 years, and ≥65 years. The study was approved by the Ethics Committee of [Institution A] (approval number: [details on title page]). A total of 906 valid responses were obtained (462 men, 443 women) with a mean age of 51.1 ± 18.4 years. Men were significantly older than women (56.6 vs. 45.6 years, P < .001), and the proportion responding “know” for sexual dysfunction awareness was 41.4% in men vs. only 11.8% in women (Supplementary Table S1). After adjustment for age and institution, women had markedly lower awareness than men (OR = 0.15, 95% CI, 0.09-0.23, P < .001) (Supplementary Table S2). This sex difference likely reflects information disparities; the 1999 introduction of oral medications for male sexual dysfunction generated substantial media attention and stimulated epidemiological research, whereas female sexual dysfunction has not benefited from comparable therapeutic innovations or public discourse. Women showed a tendency toward lower visit intention (OR = 0.73, 95% CI, 0.53-1.01, P = .061), characterized by a higher proportion selecting “would want to but have reservations” (57.5% vs. 45.4%) rather than “would actively want to” (9.8% vs. 15.4%) (Supplementary Table S1). This conditional hesitation is clinically significant and distinct from outright refusal, indicating that women are not fundamentally opposed to seeking care but require specific conditions to be met. Overall, higher awareness was associated with greater visit intention (OR = 1.47, P = .018); however, sex-stratified analysis revealed this association was significant only in men (OR = 1.58, P = .018), not in women (OR = 1.36, P = .316) (Supplementary Table S3). This suggests that simply raising awareness is unlikely to resolve women’s hesitation—something else must be addressed. In multivariable analysis, age was the strongest predictor of visit intention: the proportion expressing no intention increased from 18.4% in those aged <40 years to 54.5% for ages ≥65 (OR = 0.48 and OR = 0.23 vs. <40 years, both P < .001) (Supplementary Table S3). To identify what must be addressed for women, we examined barriers to care-seeking among 690 respondents who expressed hesitation or no intention to visit a sexual dysfunction clinic. Multivariable analysis revealed that “anxiety about treatment content” was the only barrier significantly higher in women (OR = 1.66, 95% CI, 1.10-2.49, P = .016) (Supplementary Table S4). “Embarrassment,” “lack of knowledge about how to seek care,” and “lack of interest in treatment,” which showed significant sex differences in univariate analysis, were no longer significant after adjustment, suggesting confounding by demographic differences between sexes. Regarding age-related barriers, “embarrassment” was more prevalent among younger respondents (40-64 years OR = 0.35, ≥65 years OR = 0.19 vs. <40 years, both P < .001), whereas “lack of interest in treatment” was more prevalent among older respondents (40-64 years OR = 1.77, P = .030; ≥65 years OR = 2.90, P = .001). Women’s priorities further clarify what is needed. Women placed significantly greater importance on “clear explanations” (OR = 1.49, 95% CI, 1.07-2.08, P = .018) and “a comfortable environment for discussion” (OR = 2.28, 95% CI, 1.60-3.23, P < .001) (Supplementary Table S5). Consistent with these preferences, 83.0% of women preferred female physicians (vs. 0% preferring male physicians) and 68.7% preferred gynecology over urology (1.0%) (Supplementary Figure S1). These findings explain why visit intention was significantly higher at [Institution D] (OR = 1.93, P = .003) (Supplementary Table S3), a women-centered facility with predominantly female staff—demonstrating that when structural conditions meet women’s needs, visit intention improves. Taken together, these findings answer the question posed in the title: women hesitate not because they are unaware of sexual dysfunction, but because they are anxious about treatment content and lack the structural conditions—female physicians, gynecological settings, and clear treatment information—needed to seek care. These findings are consistent with the Health Belief Model, in which perceived barriers outweigh perceived benefits when treatment information is insufficient. Awareness alone does not translate into visit intention for women, as shown by the non-significant awareness–intention association in the sex-stratified analysis. This contrasts with men, for whom awareness remains a meaningful predictor of visit intention. Awareness-raising campaigns may promote care-seeking in men; for women, the present analysis found awareness alone insufficient, though no campaigns comparable in scale to those for men have been conducted for women, and their potential impact remains to be determined. To address women’s hesitation, healthcare providers should offer specific treatment information—including safety, procedures, and expected outcomes—and create clinical environments where women feel comfortable discussing sexual health. Collaboration with gynecology and assignment of female physicians are essential when developing sexual dysfunction services. Age-specific approaches are equally warranted: privacy-sensitive care for younger patients who cite embarrassment as a primary barrier, and emphasis on QOL benefits for older patients who tend to dismiss sexual dysfunction as unimportant. A strength is the large sample size across diverse healthcare settings and comprehensive examination of sex and age differences using multivariate analysis. Limitations include potential selection bias from recruiting hospital outpatients, cross-sectional design precluding causal inference, a regional sample limiting generalizability, and self-reported outcomes subject to social desirability bias. Additionally, “anxiety about treatment content” was measured using a single unvalidated item and may overlap with constructs such as stigma or fear. As participants were already engaged with healthcare, barriers in the general population may be more pronounced than those observed here. Future longitudinal studies and intervention trials are needed to confirm whether sex- and age-specific interventions can effectively improve healthcare utilization. Nevertheless, these findings provide important insights for developing targeted strategies to improve access to sexual dysfunction care. Awareness campaigns alone are insufficient; interventions that address women’s conditional hesitation by reducing treatment anxiety and improving healthcare environments offer the greatest promise. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The authors declare no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Moriwake et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: